NEUROHUMORAL CONSEQUENCES OF VASODILATOR THERAPY WITH HYDRALAZINE AND NIFEDIPINE IN SEVERE CONGESTIVE-HEART-FAILURE

被引:26
作者
ELKAYAM, U [1 ]
ROTH, A [1 ]
HSUEH, W [1 ]
WEBER, L [1 ]
FREIDENBERGER, L [1 ]
RAHIMTOOLA, SH [1 ]
机构
[1] UNIV SO CALIF, SCH MED,DEPT MED,DIV ENDOCRINOL, LOS ANGELES, CA 90033 USA
关键词
D O I
10.1016/0002-8703(86)90017-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1130 / 1138
页数:9
相关论文
共 41 条
[1]  
BELLINI G, 1984, CURR THER RES CLIN E, V35, P974
[2]   DECREASED CATECHOLAMINE SENSITIVITY AND BETA-ADRENERGIC-RECEPTOR DENSITY IN FAILING HUMAN HEARTS [J].
BRISTOW, MR ;
GINSBURG, R ;
MINOBE, W ;
CUBICCIOTTI, RS ;
SAGEMAN, WS ;
LURIE, K ;
BILLINGHAM, ME ;
HARRISON, DC ;
STINSON, EB .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (04) :205-211
[3]   ORAL HYDRALAZINE IN CHRONIC HEART-FAILURE - SUSTAINED BENEFICIAL HEMODYNAMIC-EFFECTS [J].
CHATTERJEE, K ;
PORTS, TA ;
BRUNDAGE, BH ;
MASSIE, B ;
HOLLY, AN ;
PARMLEY, WW .
ANNALS OF INTERNAL MEDICINE, 1980, 92 (05) :600-604
[4]   CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE [J].
CHIDSEY, CA ;
BRAUNWALD, E ;
MORROW, AG .
AMERICAN JOURNAL OF MEDICINE, 1965, 39 (03) :442-+
[5]   RENAL EFFECTS OF NITROPRUSSIDE AND HYDRALAZINE IN PATIENTS WITH CONGESTIVE HEART-FAILURE [J].
COGAN, JJ ;
HUMPHREYS, MH ;
CARLSON, CJ ;
RAPAPORT, E .
CIRCULATION, 1980, 61 (02) :316-323
[6]   PLASMA NOREPINEPHRINE AS A GUIDE TO PROGNOSIS IN PATIENTS WITH CHRONIC CONGESTIVE HEART-FAILURE [J].
COHN, JN ;
LEVINE, TB ;
OLIVARI, MT ;
GARBERG, V ;
LURA, D ;
FRANCIS, GS ;
SIMON, AB ;
RECTOR, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (13) :819-823
[7]  
DZAU VJ, 1983, FED PROC, V42, P3162
[8]  
EKELUND LG, 1982, ACTA MED SCAND, V212, P71
[9]   MARKED EARLY ATTENUATION OF HEMODYNAMIC-EFFECTS OF ORAL PRAZOSIN THERAPY IN CHRONIC CONGESTIVE HEART-FAILURE [J].
ELKAYAM, U ;
LEJEMTEL, TH ;
MATHUR, M ;
RIBNER, HS ;
FRISHMAN, WH ;
STROM, J ;
SONNENBLICK, EH .
AMERICAN JOURNAL OF CARDIOLOGY, 1979, 44 (03) :540-545
[10]  
ELKAYAM U, 1984, J AM COLL CARDIOL, V3, P478